155 related articles for article (PubMed ID: 11590897)
1. The predictive parameters of erythropoietin hyporesponsiveness in patients on continuous ambulatory peritoneal dialysis.
Kim JK; Park BS; Park MJ; Choi W; Ma SK; Nah MY; Yeum CH; Jung K; Lee SC; Kim SW; Kim NH; Kang YJ; Choi KC
Korean J Intern Med; 2001 Jun; 16(2):110-7. PubMed ID: 11590897
[TBL] [Abstract][Full Text] [Related]
2. Factors related to erythropoietin hypo-responsiveness in patients on chronic peritoneal dialysis.
Wei M; Bargman JM; Oreopoulos DG
Int Urol Nephrol; 2007; 39(3):935-40. PubMed ID: 17534732
[TBL] [Abstract][Full Text] [Related]
3. Epoetin requirement does not depend on dialysis dose when Kt/N > 1.33 in patients on regular dialysis treatment with cellulosic membranes and adequate iron stores.
Movilli E; Cancarini GC; Vizzardi V; Camerini C; Brunori G; Cassamali S; Maiorca R
J Nephrol; 2003; 16(4):546-51. PubMed ID: 14696757
[TBL] [Abstract][Full Text] [Related]
4. Efficient monthly subcutaneous administration of darbepoetin in stable CAPD patients.
Theodoridis M; Passadakis P; Kriki P; Panagoutsos S; Yannatos E; Kantartzi K; Sivridis D; Vargemezis V
Perit Dial Int; 2005; 25(6):564-9. PubMed ID: 16411523
[TBL] [Abstract][Full Text] [Related]
5. Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients.
Gunnell J; Yeun JY; Depner TA; Kaysen GA
Am J Kidney Dis; 1999 Jan; 33(1):63-72. PubMed ID: 9915269
[TBL] [Abstract][Full Text] [Related]
6. Inflammation, peritoneal transport, and response to erythropoietin in peritoneal dialysis patients.
Pilkey RM; Morton AR; Iliescu EA
Adv Perit Dial; 2001; 17():153-7. PubMed ID: 11510266
[TBL] [Abstract][Full Text] [Related]
7. Toward targets for initiation of chronic dialysis.
Mehrotra R; Saran R; Moore HL; Prowant BF; Khanna R; Twardowski ZJ; Nolph KD
Perit Dial Int; 1997; 17(5):497-508. PubMed ID: 9358533
[TBL] [Abstract][Full Text] [Related]
8. Oral zinc supplementation reduces the erythropoietin responsiveness index in patients on hemodialysis.
Kobayashi H; Abe M; Okada K; Tei R; Maruyama N; Kikuchi F; Higuchi T; Soma M
Nutrients; 2015 May; 7(5):3783-95. PubMed ID: 25988769
[TBL] [Abstract][Full Text] [Related]
9. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease.
Ifudu O; Feldman J; Friedman EA
N Engl J Med; 1996 Feb; 334(7):420-5. PubMed ID: 8552143
[TBL] [Abstract][Full Text] [Related]
10. C-reactive protein but not hepcidin, NGAL and transferrin determines the ESA resistance in hemodialysis patients.
Yılmaz I; Ozkok A; Kostek O; Kolukısa A; Duran I; Odabaş AR; Kemal Işman F; Işbilen Başok B
Ren Fail; 2016; 38(1):89-95. PubMed ID: 26539647
[TBL] [Abstract][Full Text] [Related]
11. The anemia in continuous ambulatory peritoneal dialysis patients is related to Kt/V index.
Opatrný K; Opatrná S; Sefrna F; Wirth J
Artif Organs; 1999 Jan; 23(1):65-9. PubMed ID: 9950181
[TBL] [Abstract][Full Text] [Related]
12. Subcutaneous epoetin beta in renal anemia: an open multicenter dose titration study of patients on continuous peritoneal dialysis.
Bárány P; Clyne N; Hylander B; Johansson AC; Simonsen O; Larsson R; Frisenette-Fich C; Svensson B; Helmers C
Perit Dial Int; 1995; 15(1):54-60. PubMed ID: 7734561
[TBL] [Abstract][Full Text] [Related]
13. Relationship between residual renal function, inflammation, and anemia in peritoneal dialysis.
Pérez-Flores I; Coronel F; Cigarrán S; Herrero JA; Calvo N
Adv Perit Dial; 2007; 23():140-3. PubMed ID: 17886621
[TBL] [Abstract][Full Text] [Related]
14. Does parathyroid hormone affect erythropoietin therapy in dialysis patients?
Al-Hilali N; Al-Humoud H; Ninan VT; Nampoory MR; Puliyclil MA; Johny KV
Med Princ Pract; 2007; 16(1):63-7. PubMed ID: 17159367
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Effect of Vitamin D Deficiency on Anemia and Erythropoietin Hyporesponsiveness in Patients of Chronic Kidney Disease.
Nand N; Mittal R
J Assoc Physicians India; 2017 Feb; 65(2):38-42. PubMed ID: 28457030
[TBL] [Abstract][Full Text] [Related]
16. Anemia management of adult hemodialysis patients in the US results: from the 1997 ESRD Core Indicators Project.
Frankenfield D; Johnson CA; Wish JB; Rocco MV; Madore F; Owen WF
Kidney Int; 2000 Feb; 57(2):578-89. PubMed ID: 10652035
[TBL] [Abstract][Full Text] [Related]
17. Predictors of erythropoietin responsiveness in chronic hemodialysis patients.
Tonelli M; Blake PG; Muirhead N
ASAIO J; 2001; 47(1):82-5. PubMed ID: 11199321
[TBL] [Abstract][Full Text] [Related]
18. Adequacy of dialysis reduces the doses of recombinant erythropoietin independently from the use of biocompatible membranes in haemodialysis patients.
Movilli E; Cancarini GC; Zani R; Camerini C; Sandrini M; Maiorca R
Nephrol Dial Transplant; 2001 Jan; 16(1):111-4. PubMed ID: 11209002
[TBL] [Abstract][Full Text] [Related]
19. Factors Contributing to Erythropoietin Hyporesponsiveness in Patients on Long-Term Continuous Ambulatory Peritoneal Dialysis: A Cross-Sectional Study.
Hara T; Mukai H; Nakashima T; Sagara R; Furusho M; Miura S; Toyonaga J; Sugawara K; Takeda K
Nephron Extra; 2015; 5(3):79-86. PubMed ID: 26648974
[TBL] [Abstract][Full Text] [Related]
20. Selected outcome criteria and adequacy of dialysis in diabetic and elderly patients on CAPD therapy.
Mooraki A; Kliger AS; Juergensen P; Gorban-Brennan N; Finkelstein FO
Adv Perit Dial; 1994; 10():89-93. PubMed ID: 7999872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]